BackVerastem Overview
Verastem Inc

Verastem Target Price

Analysts' average 12-month price target for Verastem is $14.

Get informed when a big investor buys or sells

+ Follow

Share Price

$7.12

Average Target Price

$14.0096.5% upside

7 analysts in the last 4 months

High: $18 | Low: $8

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-10Mizuho Securities$1382.5% upsideOpen
2026-08-07Guggenheim$1268.5% upsideOpen
2026-07-07RBC Capital$1496.5% upsideOpen
2026-06-24RBC CapitalLeonid Timashev$15110.6% upsideOpen
2026-06-23Jefferies$812.3% upsideOpen
2026-05-08BTIG$18152.7% upsideOpen
2026-05-08Industrial Alliance Securities$18152.7% upsideOpen
2026-03-05JefferiesClara Dong$19166.7% upsideOpen
2026-02-19Mizuho Securities$18152.7% upsideOpen
2025-10-29Mizuho Securities$15110.6% upsideOpen
2025-10-21Mizuho SecuritiesGraig Suvannavejh$1496.5% upsideOpen
2025-10-21H.C. WainwrightSwayampakula Ramakanth$1496.5% upsideOpen
2025-10-20RBC Capital$1382.5% upsideOpen
2025-03-24GuggenheimMichael Schmidt$1496.5% upsideOpen
2025-03-24H.C. Wainwright$1040.4% upsideOpen
2024-07-29Mizuho SecuritiesGraig Suvannavejh$71.7% downsideOpen
2024-05-24BTIGJustin Zelin$1382.5% upsideOpen
2022-04-15RBC CapitalGregory Renza$529.8% downsideOpen

Verastem (VSTM) FAQ

As of the most recent data, VSTM shows a target price of $14. Scroll down for historical charts and peer comparison views.

If Verastem moved to the average analyst target of $14, shares would be roughly 96.5% higher than $7.12. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Verastem's earnings trajectory.

Besides this target price page, Stockcircle has Verastem's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $14) with ownership activity and broader fundamentals.

Verastem's target price is $14; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.